94 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 2 | next »
Genei Gene descriptioni x Evidencei x Tissuei Braini Single celli Subcelli Canceri Bloodi Cell linei Struct & Inti Prognostic p-valuei x
ABHD4Abhydrolase domain containing 4, N-acyl phospholipase B
Lung Adenocarcinoma (TCGA): 2.58e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.28e-4
Rectum Adenocarcinoma (TCGA): 9.69e-4
ADAMTS14ADAM metallopeptidase with thrombospondin type 1 motif 14
Lung Adenocarcinoma (validation): 2.80e-4
Uterine Corpus Endometrial Carcinoma (TCGA): 7.77e-4
ADCY7Adenylate cyclase 7
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 1.13e-4
Lung Squamous Cell Carcinoma (TCGA): 7.31e-4
ANLNAnillin, actin binding protein
Liver Hepatocellular Carcinoma (validation): 2.40e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.71e-9
Lung Adenocarcinoma (TCGA): 9.34e-8
Pancreatic Adenocarcinoma (TCGA): 1.84e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.73e-6
Liver Hepatocellular Carcinoma (TCGA): 9.35e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.27e-4
Lung Adenocarcinoma (validation): 1.34e-4
Kidney Chromophobe (TCGA): 6.88e-4
APOBEC3BApolipoprotein B mRNA editing enzyme catalytic subunit 3B
Liver Hepatocellular Carcinoma (validation): 1.96e-5
Lung Adenocarcinoma (validation): 2.50e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 4.61e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.46e-4
ARHGAP11ARho GTPase activating protein 11A
Liver Hepatocellular Carcinoma (validation): 1.07e-7
Lung Adenocarcinoma (TCGA): 1.46e-5
Kidney Renal Clear Cell Carcinoma (validation): 2.28e-5
Pancreatic Adenocarcinoma (TCGA): 1.00e-4
ARL11ADP ribosylation factor like GTPase 11
ASF1BAnti-silencing function 1B histone chaperone
Liver Hepatocellular Carcinoma (validation): 1.21e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.29e-9
Kidney Chromophobe (TCGA): 8.56e-7
Kidney Renal Clear Cell Carcinoma (validation): 1.59e-6
Pancreatic Adenocarcinoma (TCGA): 1.09e-5
Lung Adenocarcinoma (validation): 3.22e-5
Lung Adenocarcinoma (TCGA): 1.50e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 1.57e-4
Stomach Adenocarcinoma (TCGA): 4.66e-4
Liver Hepatocellular Carcinoma (TCGA): 5.76e-4
Lung Squamous Cell Carcinoma (TCGA): 9.62e-4
AURKAAurora kinase A
Liver Hepatocellular Carcinoma (validation): 1.12e-9
Kidney Chromophobe (TCGA): 1.06e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.13e-6
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.82e-6
Kidney Renal Clear Cell Carcinoma (validation): 3.56e-6
Liver Hepatocellular Carcinoma (TCGA): 6.05e-5
Lung Adenocarcinoma (TCGA): 6.46e-5
Pancreatic Adenocarcinoma (TCGA): 2.32e-4
Bladder Urothelial Carcinoma (TCGA): 7.74e-4
BRCA2BRCA2 DNA repair associated
CASP10Caspase 10
Liver Hepatocellular Carcinoma (TCGA): 4.89e-5
CCDC73Coiled-coil domain containing 73
Liver Hepatocellular Carcinoma (validation): 3.33e-5
CCNA2Cyclin A2
Liver Hepatocellular Carcinoma (validation): 2.55e-8
Kidney Renal Clear Cell Carcinoma (TCGA): 9.34e-8
Lung Adenocarcinoma (TCGA): 2.28e-6
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.35e-6
Pancreatic Adenocarcinoma (TCGA): 3.55e-5
Liver Hepatocellular Carcinoma (TCGA): 4.19e-5
Kidney Chromophobe (TCGA): 3.24e-4
Kidney Renal Clear Cell Carcinoma (validation): 3.99e-4
Lung Adenocarcinoma (validation): 4.74e-4
CCNB1Cyclin B1
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.11e-10
Liver Hepatocellular Carcinoma (validation): 3.97e-10
Liver Hepatocellular Carcinoma (TCGA): 3.16e-9
Lung Adenocarcinoma (TCGA): 4.69e-7
Kidney Renal Clear Cell Carcinoma (validation): 2.43e-5
Lung Adenocarcinoma (validation): 4.74e-4
Kidney Chromophobe (TCGA): 5.21e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 7.61e-4
CCNB2Cyclin B2
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.05e-12
Kidney Renal Clear Cell Carcinoma (TCGA): 3.29e-9
Liver Hepatocellular Carcinoma (validation): 4.73e-8
Lung Adenocarcinoma (TCGA): 1.07e-5
Liver Hepatocellular Carcinoma (TCGA): 1.31e-5
Pancreatic Adenocarcinoma (TCGA): 2.47e-5
Kidney Chromophobe (TCGA): 4.17e-5
Kidney Renal Clear Cell Carcinoma (validation): 4.36e-5
Lung Adenocarcinoma (validation): 2.43e-4
CDC45Cell division cycle 45
Kidney Renal Clear Cell Carcinoma (TCGA): 3.12e-10
Liver Hepatocellular Carcinoma (validation): 1.41e-9
Liver Hepatocellular Carcinoma (TCGA): 6.41e-7
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.74e-5
Lung Adenocarcinoma (TCGA): 3.20e-5
Ovary Serous Cystadenocarcinoma (validation): 3.70e-5
Kidney Renal Clear Cell Carcinoma (validation): 2.75e-4
Pancreatic Adenocarcinoma (TCGA): 4.93e-4
CDC6Cell division cycle 6
Liver Hepatocellular Carcinoma (validation): 2.27e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.73e-9
Liver Hepatocellular Carcinoma (TCGA): 2.21e-6
Lung Adenocarcinoma (TCGA): 8.24e-5
Kidney Renal Clear Cell Carcinoma (validation): 7.38e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 8.46e-4
Pancreatic Adenocarcinoma (TCGA): 8.62e-4
CDCA2Cell division cycle associated 2
Lung Adenocarcinoma (TCGA): 7.02e-6
CDCA8Cell division cycle associated 8
Liver Hepatocellular Carcinoma (TCGA): 2.96e-11
Kidney Renal Clear Cell Carcinoma (TCGA): 1.92e-10
Liver Hepatocellular Carcinoma (validation): 1.35e-9
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.42e-8
Lung Adenocarcinoma (TCGA): 1.18e-4
Kidney Chromophobe (TCGA): 3.91e-4
Kidney Renal Clear Cell Carcinoma (validation): 6.46e-4
CDK1Cyclin dependent kinase 1
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.43e-14
Liver Hepatocellular Carcinoma (validation): 3.77e-7
Liver Hepatocellular Carcinoma (TCGA): 5.56e-7
Pancreatic Adenocarcinoma (TCGA): 7.18e-7
Lung Adenocarcinoma (TCGA): 9.03e-7
Kidney Renal Clear Cell Carcinoma (validation): 2.29e-6
Kidney Chromophobe (TCGA): 5.73e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 6.98e-5
CDKN3Cyclin dependent kinase inhibitor 3
Liver Hepatocellular Carcinoma (validation): 5.00e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.30e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.38e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 9.21e-7
Lung Adenocarcinoma (TCGA): 3.93e-6
Kidney Chromophobe (TCGA): 4.42e-6
Ovary Serous Cystadenocarcinoma (validation): 8.24e-5
Pancreatic Adenocarcinoma (TCGA): 6.57e-4
Liver Hepatocellular Carcinoma (TCGA): 7.07e-4
CDT1Chromatin licensing and DNA replication factor 1
Liver Hepatocellular Carcinoma (validation): 2.14e-9
Liver Hepatocellular Carcinoma (TCGA): 3.70e-7
Lung Adenocarcinoma (TCGA): 1.00e-5
Skin Cuteneous Melanoma (TCGA): 4.47e-4
CENPECentromere protein E
Pancreatic Adenocarcinoma (TCGA): 2.15e-5
Lung Adenocarcinoma (TCGA): 2.32e-5
Lung Adenocarcinoma (validation): 5.21e-4
CENPKCentromere protein K
Liver Hepatocellular Carcinoma (validation): 1.42e-5
Lung Adenocarcinoma (TCGA): 2.90e-5
Lung Adenocarcinoma (validation): 3.90e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.48e-4
Liver Hepatocellular Carcinoma (TCGA): 4.01e-4
Kidney Chromophobe (TCGA): 4.87e-4
CENPMCentromere protein M
Liver Hepatocellular Carcinoma (validation): 3.44e-8
Kidney Renal Clear Cell Carcinoma (TCGA): 5.64e-8
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.77e-7
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 4.28e-6
Liver Hepatocellular Carcinoma (TCGA): 8.71e-6
Lung Adenocarcinoma (TCGA): 1.12e-5
Glioblastoma Multiforme (validation): 6.23e-4
Kidney Renal Clear Cell Carcinoma (validation): 7.79e-4
CIP2ACellular inhibitor of PP2A
Lung Adenocarcinoma (TCGA): 7.07e-5
Pancreatic Adenocarcinoma (TCGA): 5.87e-4
Lung Adenocarcinoma (validation): 7.59e-4
COG4Component of oligomeric golgi complex 4
Liver Hepatocellular Carcinoma (TCGA): 2.28e-6
Glioblastoma Multiforme (validation): 1.10e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 3.41e-4
DEPDC1DEP domain containing 1
Liver Hepatocellular Carcinoma (validation): 2.37e-10
Liver Hepatocellular Carcinoma (TCGA): 2.07e-6
Lung Adenocarcinoma (TCGA): 4.61e-5
Bladder Urothelial Carcinoma (TCGA): 6.75e-4
DEPDC1BDEP domain containing 1B
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.03e-8
Lung Adenocarcinoma (TCGA): 4.53e-7
Liver Hepatocellular Carcinoma (validation): 5.68e-6
Lung Adenocarcinoma (validation): 4.16e-5
Liver Hepatocellular Carcinoma (TCGA): 1.37e-4
Kidney Renal Clear Cell Carcinoma (validation): 1.83e-4
DIAPH3Diaphanous related formin 3
Pancreatic Adenocarcinoma (TCGA): 4.34e-5
Lung Adenocarcinoma (TCGA): 4.45e-5
Lung Adenocarcinoma (validation): 9.44e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.06e-4
DTLDenticleless E3 ubiquitin protein ligase homolog
Lung Adenocarcinoma (TCGA): 4.58e-7
Liver Hepatocellular Carcinoma (validation): 9.24e-6
Kidney Renal Clear Cell Carcinoma (validation): 1.50e-4
Liver Hepatocellular Carcinoma (TCGA): 1.58e-4
Lung Adenocarcinoma (validation): 2.51e-4
Pancreatic Adenocarcinoma (TCGA): 5.08e-4
E2F1E2F transcription factor 1
Liver Hepatocellular Carcinoma (validation): 6.43e-7
Kidney Chromophobe (TCGA): 1.15e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.52e-5
Pancreatic Adenocarcinoma (TCGA): 3.91e-5
Liver Hepatocellular Carcinoma (TCGA): 1.10e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.49e-4
E2F2E2F transcription factor 2
Stomach Adenocarcinoma (TCGA): 5.47e-4
Glioblastoma Multiforme (validation): 7.62e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 9.85e-4
E2F7E2F transcription factor 7
Lung Adenocarcinoma (validation): 2.22e-4
Pancreatic Adenocarcinoma (validation): 3.44e-4
E2F8E2F transcription factor 8
Liver Hepatocellular Carcinoma (TCGA): 6.37e-6
Liver Hepatocellular Carcinoma (validation): 8.34e-5
Lung Adenocarcinoma (validation): 1.00e-4
Kidney Renal Clear Cell Carcinoma (validation): 1.38e-4
Skin Cuteneous Melanoma (TCGA): 5.60e-4
Lung Adenocarcinoma (TCGA): 6.48e-4
EME1Essential meiotic structure-specific endonuclease 1
Lung Adenocarcinoma (validation): 3.24e-6
Liver Hepatocellular Carcinoma (validation): 5.71e-6
Lung Adenocarcinoma (TCGA): 7.03e-4
ESCO2Establishment of sister chromatid cohesion N-acetyltransferase 2
Rectum Adenocarcinoma (TCGA): 2.79e-5
Lung Adenocarcinoma (TCGA): 1.64e-4
Colon Adenocarcinoma (TCGA): 1.70e-4
Pancreatic Adenocarcinoma (TCGA): 8.43e-4
EXO1Exonuclease 1
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.01e-8
Liver Hepatocellular Carcinoma (validation): 6.82e-8
Liver Hepatocellular Carcinoma (TCGA): 1.87e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 6.65e-5
Kidney Renal Clear Cell Carcinoma (validation): 6.77e-5
Lung Adenocarcinoma (TCGA): 1.17e-4
Lung Adenocarcinoma (validation): 2.53e-4
Skin Cuteneous Melanoma (TCGA): 2.89e-4
FAM111BFAM111 trypsin like peptidase B
Lung Adenocarcinoma (TCGA): 9.21e-8
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.43e-6
Kidney Chromophobe (TCGA): 1.68e-5
Pancreatic Adenocarcinoma (TCGA): 2.03e-5
Liver Hepatocellular Carcinoma (TCGA): 3.24e-4
Thyroid Carcinoma (TCGA): 3.90e-4
Lung Adenocarcinoma (validation): 7.47e-4
FAM72AFamily with sequence similarity 72 member A
Lung Adenocarcinoma (TCGA): 4.13e-5
Liver Hepatocellular Carcinoma (TCGA): 4.73e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 9.67e-5
FAM72DFamily with sequence similarity 72 member D
Lung Adenocarcinoma (TCGA): 6.88e-6
Lung Adenocarcinoma (validation): 2.04e-5
FANCAFA complementation group A
Kidney Renal Clear Cell Carcinoma (TCGA): 3.23e-5
Prostate Adenocarcinoma (TCGA): 8.09e-4
FBXO43F-box protein 43
FOXM1Forkhead box M1
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.74e-10
Kidney Renal Clear Cell Carcinoma (TCGA): 1.18e-7
Liver Hepatocellular Carcinoma (validation): 1.59e-7
Kidney Renal Clear Cell Carcinoma (validation): 6.03e-6
Lung Adenocarcinoma (TCGA): 1.94e-5
Lung Adenocarcinoma (validation): 7.26e-5
Liver Hepatocellular Carcinoma (TCGA): 7.75e-5
Pancreatic Adenocarcinoma (TCGA): 4.20e-4
GINS4GINS complex subunit 4
Stomach Adenocarcinoma (TCGA): 5.83e-4
Liver Hepatocellular Carcinoma (TCGA): 6.35e-4
Lung Squamous Cell Carcinoma (validation): 9.43e-4
Lung Adenocarcinoma (TCGA): 9.94e-4
GRNGranulin precursor
Kidney Renal Clear Cell Carcinoma (TCGA): 5.65e-4
Glioblastoma Multiforme (TCGA): 6.79e-4
HASPINHistone H3 associated protein kinase
Lung Adenocarcinoma (TCGA): 8.25e-5
Glioblastoma Multiforme (validation): 5.62e-4
Bladder Urothelial Carcinoma (TCGA): 9.69e-4
ITGB6Integrin subunit beta 6
Pancreatic Adenocarcinoma (TCGA): 7.31e-6
Lung Squamous Cell Carcinoma (TCGA): 9.36e-4
KIF11Kinesin family member 11
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.15e-10
Liver Hepatocellular Carcinoma (TCGA): 8.81e-7
Liver Hepatocellular Carcinoma (validation): 1.37e-5
Lung Adenocarcinoma (TCGA): 3.21e-5
Pancreatic Adenocarcinoma (TCGA): 1.19e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 3.07e-4
Kidney Renal Clear Cell Carcinoma (validation): 8.15e-4
Page of 2 | next »